Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Financing › Details

Rebiotix–SEVERAL: investment, 2014 financing round Series B $25m

	Period	2014-01-01
	Predecessor	Rebiotix–SEVERAL: investment, 2011 seed financing round $5m
	Successor	Rebiotix–Ferring: investment, 201804 acquisition of Rebiotix by Ferring
	Money taker	Rebiotix Inc.
	Group	Ferring (Paulsen Foundation) (Group)
	Money source	SEVERAL
	Product	Microbiota Restoration Therapy™ (MRT™) drug platform
	Product 2	RBX2660 microbiotic treatment

Record changed: 2024-12-20

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Register 650x200px

More documents for Ferring (Paulsen Foundation) (Group)

[1] Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex....
[2] Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck....
[3] Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris....
[4] Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA....
[5] Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC....
[6] Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)